Neumora Therapeutics Total Revenue

Neumora Therapeutics (NMRA) currently reports a total revenue of $0 as of March 2026. In the prior-year period, the figure was $0. That is below the sector sector average of $1.1B. Use the charts on this page to explore Neumora Therapeutics's total revenue history and peer comparisons.

Neumora Therapeutics's total revenue changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Neumora Therapeutics's total revenue of $0 is lower than the its sector sector average of $1.1B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Neumora Therapeutics reported $0 in total revenue as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $1.1B. From there, open related valuation or income-statement pages for Neumora Therapeutics, and consider following NMRA for alerts when major investors trade the stock.